Fundacion Privada Instituto de Salud Global Barcelona

Spain

Back to Profile

1-11 of 11 for Fundacion Privada Instituto de Salud Global Barcelona Sort by
Query
Aggregations
IP Type
        Patent 6
        Trademark 5
Jurisdiction
        Europe 5
        World 4
        United States 2
Date
2025 June 1
2025 (YTD) 3
2024 1
2023 2
2021 1
See more
IPC Class
A61P 31/04 - Antibacterial agents 3
A61P 33/06 - Antimalarials 2
C07D 213/38 - Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom 2
A01N 57/02 - Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups , , , 1
A01N 57/08 - Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups , , , containing heterocyclic radicals 1
See more
NICE Class
42 - Scientific, technological and industrial services, research and design 4
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 4
41 - Education, entertainment, sporting and cultural services 3
09 - Scientific and electric apparatus and instruments 2
16 - Paper, cardboard and goods made from these materials 1
See more
Status
Pending 2
Registered / In Force 9

1.

SCIENCEPEAKS

      
Application Number 019202063
Status Pending
Filing Date 2025-06-13
Owner FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 35 - Advertising and business services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Software; Interfaces for computers; Artificial intelligence software for analysis; Machine learning software for healthcare; Artificial intelligence software for healthcare; Workout logging software; Health monitoring software; Software for monitoring, analysing, controlling and running physical world operations; Downloadable software applications; Mobile apps; Information retrieval applications; Web application and server software. Maintaining files and records concerning the medical condition of individuals; Health care cost review; Health care cost management; Business administration services in the field of healthcare; Data processing services in the field of healthcare; Compilation of statistics relating to health care utilization. Configuration of computer software; Software engineering; Updating of computer programs; Software development; Software design and development; Software customisation services; Smartphone software design; Design, development and programming of computer software; Advisory and information services relating to computer software; Programming of software for importing and managing data; Research and development of computer software; Research, development, design and upgrading of computer software; Support and maintenance services for computer software; Providing information about the design and development of computer software; Providing information about the design and development of computer hardware and software. Human healthcare services; Health counselling; Health risk assessment; Health assessment surveys; Preparation of reports relating to health care matters; Health advice and information services.

2.

ELVITEGRAVIR TO TREAT MULTIDRUG-RESISTANT GRAM-POSITIVE BACTERIA INFECTIONS

      
Application Number EP2024079248
Publication Number 2025/083091
Status In Force
Filing Date 2024-10-16
Publication Date 2025-04-24
Owner
  • FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
  • FUNDACIÓ DE RECERCA CLÍNIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER (Spain)
  • UNIVERSITAT DE BARCELONA (Spain)
  • FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA (Spain)
  • CONSORCIO CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED (Spain)
  • HOSPITAL CLÍNIC DE BARCELONA (Spain)
Inventor
  • Vila Estapé, Jordi
  • Ballesté Delpierre, Clara
  • Martín Vilardell, Núria
  • Rubio, Elisa
  • Miró Meda, Josep Maria
  • Paredes Deirós, Roger

Abstract

It relates to Elvitegravir or a pharmaceutically acceptable salt thereof for use in the treatment of a bacterial infection caused by multidrug-resistant Gram-positive bacteria.

IPC Classes  ?

  • A61K 31/47 - QuinolinesIsoquinolines
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61P 31/04 - Antibacterial agents

3.

METHOD FOR DETERMINING THE X CHROMOSOME REACTIVATION LEVEL OF A FEMALE SUBJECT

      
Application Number EP2024070423
Publication Number 2025/017136
Status In Force
Filing Date 2024-07-18
Publication Date 2025-01-23
Owner FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
Inventor
  • Cáceres Domínguez, Alejandro
  • González Ruiz, Juan Ramón

Abstract

The present invention provides an in vitro method for determining the X chromosome reactivation (X-Ra) level of a female subject, the method comprising the steps of (a) determining the methylation status of at least 10 CpG sites of Table 1 in a DNA-containing sample from the female subject; and (b) calculating the fraction of the CpG sites analyzed in step (a) that are hypomethylated. The invention also provides in vitro methods for determining the biological age of a female subject, diagnosis and/or prognosis of an age-related disease or disorder or an infection, and for determining the gestational age of a fetus.

IPC Classes  ?

  • C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
  • C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

4.

COMPOUNDS FOR THE TREATMENT OF MALARIA

      
Application Number 18702874
Status Pending
Filing Date 2022-10-21
First Publication Date 2024-12-19
Owner
  • FUNDACIÓ INSTITUT DE BIOENGINYERIA DE CATALUNYA (Spain)
  • FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
  • UNIVERSITAT DE BARCELONA (Spain)
Inventor
  • Fernàndez Busquets, Xavier
  • Biosca Romanillos, Arnau
  • Bouzón Arnáiz, Inés
  • Muñoz-Torrero López-Ibarra, Diego
  • Martínez Arce, Elsa
  • Reolid Coll, Pau

Abstract

Bis(aminostyrylpyridinium) compounds of formula (I) and pharmaceutical acceptable salts thereof for use as a medicament. Additionally, multiple novel bis(aminostyrylpyridinium) compounds of formula (I) are provided. Specifically, compounds of formula (I) and compositions for use in the treatment of a disease whose etiology is based on protein aggregation. Particularly, compounds are useful in the treatment, prevention or amelioration of malaria, or symptoms, complications and/or sequelae thereof.

IPC Classes  ?

  • A61K 31/444 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone
  • A61P 33/06 - Antimalarials
  • C07D 213/38 - Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

5.

CYCLIC PEPTIDES WITH ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT (MDR) PATHOGENS

      
Application Number EP2023064218
Publication Number 2023/227771
Status In Force
Filing Date 2023-05-26
Publication Date 2023-11-30
Owner
  • FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
  • UNIVERSITAT DE BARCELONA (Spain)
  • FUNDACIÓ INSTITUT DE RECERCA BIOMÈDICA (IRB BARCELONA) (Spain)
  • HOSPITAL CLÍNIC DE BARCELONA (Spain)
Inventor
  • Vila Estapé, Jordi
  • Ballesté Delpierre, Clara
  • Moreno Morales, Javier
  • Guardiola Bagan, Salvador
  • Giralt Lledó, Ernest
  • Martín Vilardell, Núria

Abstract

The present invention relates to cyclic peptides of a particular formula (I), X1X2X3X4CX6X7X8PX10X11X12X13CX15X16X17P (SEQ ID NO: 1) (I), fwherein X1 to X17 take several meanings, and X1 and D-Pro at position 18 are linked by a peptide bond; which cyclic peptides are useful as antimicrobial agents. The invention also relates to particular bicyclic compounds, in which cysteines at positions 5 and 14 are crosslinked by a disulfide bond. The invention also relates to pharmaceutical compositions comprising the said peptides and to the medical applications of the peptides or of the compositions comprising them.

IPC Classes  ?

  • C07K 7/08 - Linear peptides containing only normal peptide links having 12 to 20 amino acids
  • C07K 7/64 - Cyclic peptides containing only normal peptide links
  • A61P 31/04 - Antibacterial agents
  • A61K 38/00 - Medicinal preparations containing peptides

6.

COMPOUNDS FOR THE TREATMENT OF MALARIA

      
Application Number EP2022079438
Publication Number 2023/067170
Status In Force
Filing Date 2022-10-21
Publication Date 2023-04-27
Owner
  • FUNDACIÓ INSTITUT DE BIOENGINYERIA DE CATALUNYA (Spain)
  • FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
  • UNIVERSITAT DE BARCELONA (Spain)
Inventor
  • Fernàndez Busquets, Xavier
  • Biosca Romanillos, Arnau
  • Bouzón Arnáiz, Inés
  • Muñoz-Torrero López-Ibarra, Diego
  • Martínez Arce, Elsa
  • Reolid Coll, Pau

Abstract

Bis(aminostyrylpyridinium) compounds of formula (I) and pharmaceutical acceptable salts thereof are provided for use as a medicament. Additionally, multiple novel bis(aminostyrylpyridinium) compounds of formula (I) are provided. The present invention relates to compounds of formula (I) and compositions for use in the treatment of a disease whose etiology is based on protein aggregation. Particularly, compounds are useful in the treatment, prevention or amelioration of malaria, or symptoms, complications and/or sequelae thereof.

IPC Classes  ?

  • A61P 33/06 - Antimalarials
  • C07D 213/38 - Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
  • C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
  • A61K 31/4427 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems

7.

Gold(III) complex, a conjugate of the gold(III) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex

      
Application Number 17050512
Grant Number 11866455
Status In Force
Filing Date 2019-04-29
First Publication Date 2021-06-24
Grant Date 2024-01-09
Owner
  • UNIVERSIDAD DE ALMERIA (Spain)
  • Fundacion Privada Instituto DE Salud Global Barcelona (Spain)
Inventor
  • Soto Gonzalez, Sara Maria
  • Ratia Loncan, Carlos
  • Cepas Lopez, Virginio
  • Lopez Cubillos, Yuly
  • Lopez Ortiz, Fernando
  • Iglesias Valdes-Solis, Maria Jose
  • Gonzalez Soengas, Raquel Maria

Abstract

A gold(III) complex, a conjugate of the gold(iII) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex. The complex comprises a group of (S{circumflex over ( )}C)-cyclometallated gold(III) complexes containing a 1,1-dithio ligand, which exhibit antibacterial activity against multiresistant microorganisms or against biofilm activity or biofilm disruption. The gold(III) complex has efficacy against a variety of microorganisms and low toxicity.

IPC Classes  ?

  • C07F 9/6558 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
  • A61P 31/04 - Antibacterial agents
  • A01N 57/02 - Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups , , ,
  • A01N 57/08 - Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having alternatively specified atoms bound to the phosphorus atom and not covered by a single one of groups , , , containing heterocyclic radicals
  • C07F 9/54 - Quaternary phosphonium compounds
  • C07F 9/572 - Five-membered rings
  • C07F 9/59 - Hydrogenated pyridine rings

8.

TRIPDOCTOR

      
Application Number 017886576
Status Registered
Filing Date 2018-04-12
Registration Date 2018-09-06
Owner
  • FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
  • HOSPITAL CLINICO DE BARCELONA (Spain)
NICE Classes  ?
  • 09 - Scientific and electric apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Computer software applications, downloadable. Medical services.

9.

ISGlobal Barcelona Institute for Global Health

      
Application Number 010710523
Status Registered
Filing Date 2012-03-08
Registration Date 2012-07-19
Owner FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
NICE Classes  ?
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Education; Providing of training; Entertainment; Sporting and cultural activities. Scientific end technological services and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software. Medical services; Veterinary services; Hygiene and beauty care for people or animals; Agriculture, horticulture and forestry services.

10.

ISGLOBAL INSTITUTO DE SALUD GLOBAL BARCELONA

      
Application Number 008763071
Status Registered
Filing Date 2009-12-16
Registration Date 2010-10-04
Owner FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
NICE Classes  ?
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Education; providing of training; entertainment; sporting and cultural activities. Scientific and technological services and research and design relating thereto; industrial analysis and research services; except the design and development of computer hardware and software. Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.

11.

CREAL centre de recerca en epidemiologia ambiental

      
Application Number 006465991
Status Registered
Filing Date 2007-11-26
Registration Date 2008-11-11
Owner FUNDACIÓN PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (Spain)
NICE Classes  ?
  • 16 - Paper, cardboard and goods made from these materials
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Printed publications, books and magazines; catalogues, envelopes, letters, invoices, cards, diaries (other than electronic), posters, calendars, news sheets and printed matter in general; school supplies. Educational, training and teaching services; arranging and conducting of conferences, congresses, courses, colloquiums, seminars and symposiums; on-line electronic publication of books and newspapers, publication of texts (other than publicity texts); publication of books; book lending; correspondence courses and courses via global computer networks. Scientific research services for medical purposes; bacteriological, biological and chemical research; chemical analysis services; scientific and technological services and research and design relating thereto.